The Prognostic Value of Lipoprotein-Associated Phospholipase A2 in the Long-Term Care of Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

about

The Prognostic Value of Lipoprotein-Associated Phospholipase A2 in the Long-Term Care of Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

Item

http://www.wikidata.org/entity/Q50089457

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The Prognostic Value of Lipopr ...... taneous Coronary Intervention.

@en

The Prognostic Value of Lipopr ...... taneous Coronary Intervention.

@nl

type

Item

label

The Prognostic Value of Lipopr ...... taneous Coronary Intervention.

@en

The Prognostic Value of Lipopr ...... taneous Coronary Intervention.

@nl

prefLabel

The Prognostic Value of Lipopr ...... taneous Coronary Intervention.

@en

The Prognostic Value of Lipopr ...... taneous Coronary Intervention.

@nl

P1476

The Prognostic Value of Lipopr ...... utaneous Coronary Intervention

@en

P2093

Hong Wang

http://www.w3.org/2001/XMLSchema#string

Lijiao Yang

http://www.w3.org/2001/XMLSchema#string

Tingting Han

http://www.w3.org/2001/XMLSchema#string

Wenfeng Wang

http://www.w3.org/2001/XMLSchema#string

Yida Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Recommendations for chamber quantification.

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati

Lipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk.

Clinical end points in coronary stent trials: a case for standardized definitions.

Lp-PLA₂- a novel risk factor for high-risk coronary and carotid artery disease.

Variation of lipoprotein associated phospholipase A2 across demographic characteristics and cardiovascular risk factors: a systematic review of the literature.

Mechanisms of acute coronary syndromes and their implications for therapy.

Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies.

Mean platelet volume and coronary artery disease: a systematic review and meta-analysis.

P304

822-827

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1076029617737837

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29121808

http://www.w3.org/2001/XMLSchema#string

P921

lipoprotein

P932

6714881

http://www.w3.org/2001/XMLSchema#string